Safe Orthopaedics announces the 20,000th kit sold and the success of the evaluation phase of Sycamore

Written by on November 26, 2021


Éragny-sur-Oise, Fleurieux-sur-l’Arbresle, November 25, 2021 at 5:45 pm CET – Protected Orthopaedics (FR0013467123 – ALSAF), an organization specializing within the design, manufacture and advertising and marketing of ready-to-use applied sciences for again surgical procedure, notably protected for emergency-treated vertebral fractures, publicizes the 20,000th package offered, and the success of the analysis part of Sycamore, the novel vertebral compression fracture (VCF) remedy.

Firstly, Protected Orthopaedics has efficiently reached the numerous mark of 20,000 instrument kits offered throughout the globe. With this achievement many sufferers have been efficiently handled utilizing Protected Orthopaedics’ proprietary ready-to-use expertise that delivers vital advantages to the hospital, the surgical staff, and the affected person.

On this subject, Nik Beyer, Chief Business Officer of Protected Orthopaedics says: “Regardless of vital market headwinds I’m delighted that by way of the arduous work and willpower of our direct gross sales groups, distribution companions and assist groups now we have continued to show that there’s a actual, and rising, un-met want for our ready-to-use expertise within the international backbone market.”

Secondly, by way of shut collaboration with surgeons in France and Germany, Protected Orthopaedics is coming to the top of a profitable analysis part for its novel vertebral compression fracture (VCF) remedy, Sycamore.  With the completion of this part Sycamore is prepared for launch early 2022 in choose markets.

Nik Beyer feedback: “Sycamore is an thrilling product for our portfolio, a brand new idea to the market that guarantees to ship vital progress by way of 2022 and past in a VCF market that continues to indicate year-on-year progress.  Market tendencies confirmed us that the options accessible to surgeons to handle these hard-to-treat sufferers don’t all the time obtain the most effective outcomes, Sycamore is designed to fulfill these calls for”.

Pierre Dumouchel, CEO & Chairman of Protected Group concludes: “It’s with nice satisfaction that we make this announcement right this moment. Our focus has all the time been on delivering the very best consequence for sufferers and it’s a privilege to have contributed to the optimum remedy of so many sufferers.  To ship this milestone in powerful market circumstances, throughout a pandemic, and follow-up with a significant piece of product growth in Sycamore is testomony to the funding now we have made in each our business and innovation enterprise items and the shut working partnerships now we have with our professional surgeons.  For VCF sufferers, a long-term correction of the fracture is vital to delivering the most effective affected person consequence.  Our Sycamore implant is designed to ship precisely that”.

About Protected Group
Protected Group is a French medical expertise group that brings collectively Protected Orthopaedics, a pioneer in ready-to-use applied sciences for backbone pathologies, and Protected Medical (previously LCI Medical), a subcontractor of medical units for orthopedic surgical procedure. The group employs roughly 150 folks.

Protected Orthopaedics develops and manufactures kits combining sterile implants and single-use devices, accessible at any time to the surgeon. These applied sciences are a part of a minimally invasive strategy geared toward decreasing the chance of contamination and an infection, for the good thing about the affected person and with a optimistic impression on hospitalization instances and prices.  Protected by 18 patent households, SteriSpineTM kits are CE marked and FDA authorized. Protected Orthopaedics is headquartered within the Paris area (Eragny-sur-Oise (95610)) and has subsidiaries in the UK, Germany, the US and the Lyon area (Fleurieux-sur-l’Arbresle).

For extra info: www.safeorthopaedics.com

Protected Medical produces implantable medical units and ready-to-use devices. It has an innovation centre and two manufacturing websites in France (Fleurieux-sur-l’Arbresle, 69210) and Tunisia, providing a variety of commercial companies: design, industrialisation, machining, ending and sterile packaging. Supported by the French restoration plan in 2020, the corporate invests in additive printing and can be operational in 2022 on this new expertise.

For extra info: www.safemedical.fr

Contacts 

Protected Orthopaedics                                                                                    

François-Henri Reynaud                  
Chief Monetary and Administrative Officer                    
Tél. : +33 (0)1 34 21 50 00                              
[email protected]           

Press Relations
Ulysse Communication
Pierre-Louis Germain / +33 (0)6 64 79 97 51 / [email protected]
Bruno Arabian / +33 (0)6 87 88 47 26 / [email protected]



visit correct success for more IPO GMP


Current track

Title

Artist